The U.S. Food and Drug Administration officially approved Eli Lilly’s diabetes drug Mounjaro for treatment of obesity. Overweight people will also be able to take the drug if they have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.
The repurposed drug received Priority Review and Fast Track designations by the agency for use in weight loss and will be sold under brand name Zepbound.
